These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20443680)
1. Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma. Uddin S; Bu R; Ahmed M; Hussain AR; Ajarim D; Al-Dayel F; Bavi P; Al-kuraya KS Leuk Lymphoma; 2010 Jul; 51(7):1305-14. PubMed ID: 20443680 [TBL] [Abstract][Full Text] [Related]
2. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Uddin S; Bavi P; Siraj AK; Ahmed M; Al-Rasheed M; Hussain AR; Ahmed M; Amin T; Alzahrani A; Al-Dayel F; Abubaker J; Bu R; Al-Kuraya KS Endocr Relat Cancer; 2010 Mar; 17(1):191-202. PubMed ID: 20008098 [TBL] [Abstract][Full Text] [Related]
3. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793 [TBL] [Abstract][Full Text] [Related]
4. Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Uddin S; Hussain AR; Siraj AK; Manogaran PS; Al-Jomah NA; Moorji A; Atizado V; Al-Dayel F; Belgaumi A; El-Solh H; Ezzat A; Bavi P; Al-Kuraya KS Blood; 2006 Dec; 108(13):4178-86. PubMed ID: 16946303 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma. Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Uddin S; Bu R; Ahmed M; Abubaker J; Al-Dayel F; Bavi P; Al-Kuraya KS Mol Cancer; 2009 Sep; 8():74. PubMed ID: 19765303 [TBL] [Abstract][Full Text] [Related]
7. Expression and significance of leptin receptor, p-STAT3 and p-AKT in diffuse large B-cell lymphoma. Lin S; YuJun L; XiaoMing X; WenWen R Acta Histochem; 2014 Jan; 116(1):126-30. PubMed ID: 24054064 [TBL] [Abstract][Full Text] [Related]
8. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab. Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313 [TBL] [Abstract][Full Text] [Related]
9. Leptin exerts proliferative and anti-apoptotic effects on goose granulosa cells through the PI3K/Akt/mTOR signaling pathway. Wen R; Hu S; Xiao Q; Han C; Gan C; Gou H; Liu H; Li L; Xu H; He H; Wang J J Steroid Biochem Mol Biol; 2015 May; 149():70-9. PubMed ID: 25576904 [TBL] [Abstract][Full Text] [Related]
10. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy. Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL. Ma Y; Zhang P; Gao Y; Fan H; Zhang M; Wu J Int J Clin Exp Pathol; 2015; 8(11):14875-84. PubMed ID: 26823817 [TBL] [Abstract][Full Text] [Related]
12. SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway. Takagi Y; Shimada K; Shimada S; Sakamoto A; Naoe T; Nakamura S; Hayakawa F; Tomita A; Kiyoi H Cancer Sci; 2016 Sep; 107(9):1270-80. PubMed ID: 27348272 [TBL] [Abstract][Full Text] [Related]
13. [Effects of AKT protein kinase activation on biologic behavior of diffuse large B cell lymphoma cells]. Zhang TC; Zhou XY; Yu BH; Zhang TM; Shi DR Zhonghua Bing Li Xue Za Zhi; 2007 May; 36(5):318-23. PubMed ID: 17706139 [TBL] [Abstract][Full Text] [Related]
14. Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy. Chi M; Chen J; Ye Y; Tseng HY; Lai F; Tay KH; Jin L; Guo ST; Jiang CC; Zhang XD Curr Med Chem; 2014 Apr; 21(10):1255-67. PubMed ID: 24304284 [TBL] [Abstract][Full Text] [Related]
15. Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling. Wang J; Zhang Y; Liu X; Ma J; Liu P; Hu C; Zhang G Oncol Rep; 2014 Dec; 32(6):2557-63. PubMed ID: 25323007 [TBL] [Abstract][Full Text] [Related]
16. Fat mass and obesity-associated protein (FTO)-induced upregulation of flotillin-2 (FLOT2) contributes to cancer aggressiveness in diffuse large B-cell lymphoma (DLBCL) via activating the PI3K/Akt/mTOR signal pathway. Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A Arch Biochem Biophys; 2024 Aug; 758():110072. PubMed ID: 38914215 [TBL] [Abstract][Full Text] [Related]
17. TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods. Gao HX; Li SJ; Niu J; Ma ZP; Nuerlan A; Xue J; Wang MB; Cui WL; Abulajiang G; Sang W; Zhang W; Li XX Pathol Res Pract; 2020 Feb; 216(2):152799. PubMed ID: 31932115 [TBL] [Abstract][Full Text] [Related]
18. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631 [TBL] [Abstract][Full Text] [Related]
19. Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway. Wang D; Chen J; Chen H; Duan Z; Xu Q; Wei M; Wang L; Zhong M J Biosci; 2012 Mar; 37(1):91-101. PubMed ID: 22357207 [TBL] [Abstract][Full Text] [Related]
20. Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma. Liu J; Chang YT; Kou YY; Zhang PP; Dong QL; Guo RY; Liu LY; Lin HW; Yang F Med Oncol; 2024 Jul; 41(9):212. PubMed ID: 39073639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]